Safran SA (SAF.PA) Bundle
Dive into Safran SA's current financial snapshot: Q3 2025 revenue hit €7,852 million (+18.3% year‑over‑year) and nine‑month revenue reached €22,621 million (+14.9% y/y) as Propulsion surged 25.6% in Q3; the company reported a remarkable €4.3 billion net income for the year to June 30, 2025 (a 164% increase), with a ROE of 36.93% and a profit margin of 14.75% alongside an operating margin of 14.89%; balance sheet metrics show total shareholder equity of €13.8 billion versus total debt of €4.4 billion (debt‑to‑equity 0.29), cash and short‑term investments of €7.0 billion and free cash flow projected at €3.0-€3.2 billion for full‑year 2025, while valuation and market signals include a market cap of €122.6 billion, P/E of 28.70, EV/EBITDA of 46.44 and analysts' mean target of €337.82 (≈+9.72% upside) - read on to unpack what these figures mean for risk, liquidity (current ratio 0.93, quick ratio 0.66), growth drivers like LEAP deliveries (+15-20% expected) and aftermarket expansion, and the key threats from supply‑chain, currency and geopolitical risks
Safran SA (SAF.PA) - Revenue Analysis
Q3 2025 revenue reached €7,852 million, up 18.3% year-on-year (organic growth 18.5%), reflecting strong demand across propulsion, equipment & defense, and aircraft interiors. For the first nine months of 2025, revenue totaled €22,621 million, a 14.9% increase versus the same period in 2024 (organic +15.0%). Management projects full-year 2025 revenue growth around 10%, supported by an expected 15-20% increase in LEAP engine deliveries versus 2024. Mission Statement, Vision, & Core Values (2026) of Safran SA.
- Propulsion division led Q3 expansion with revenue growth of 25.6% in Q3 2025.
- Equipment & Defense posted solid double-digit growth of 11.7% in Q3 2025.
- Aircraft Interiors recorded 9.8% growth in Q3 2025, supported by original equipment demand.
| Metric | Q3 2025 | Q3 2024 (YoY) | 9M 2025 | 9M 2024 (YoY) |
|---|---|---|---|---|
| Total Revenue (€m) | 7,852 | +18.3% | 22,621 | +14.9% |
| Organic Growth | 18.5% | - | 15.0% | - |
| Full-year 2025 revenue guidance | ≈+10% | - | LEAP deliveries +15-20% | - |
Division-level Q3 2025 performance:
| Division | Q3 2025 Growth | Aftermarket Growth (Q3 2025) | Original Equipment Growth (Q3 2025) |
|---|---|---|---|
| Propulsion | +25.6% | +21.1% | +34.4% |
| Equipment & Defense | +11.7% | +11.5% | +11.9% |
| Aircraft Interiors | +9.8% | +6.8% | +11.7% |
- Propulsion: growth driven by both aftermarket services (+21.1%) and OE sales (+34.4%), indicating robust engine demand and service activity.
- Equipment & Defense: balanced growth in aftermarket and OE (~+11.5% and +11.9%) suggests steady defense procurement and airline fleet investment.
- Aircraft Interiors: stronger OE expansion (+11.7%) relative to aftermarket (+6.8%), consistent with continued aircraft deliveries and cabin retrofits.
Key operational drivers to monitor going forward:
- LEAP engine delivery cadence (guidance +15-20% for 2025 vs 2024) and its impact on Propulsion OEM revenue.
- Aftermarket service momentum across divisions supporting recurring revenue and margin resilience.
- Execution on supply chain and production ramp to meet full-year ~10% revenue guidance.
Safran SA (SAF.PA) - Profitability Metrics
Safran SA reported outstanding profitability for the year ending June 30, 2025, driven by recovery in aerospace markets, margin expansion and operational leverage.- Return on Equity (ROE): 36.93% (Dec 2025) vs. historical average 10.32% - a large improvement in shareholder returns.
- Net income: €4.3 billion for year ending June 30, 2025 - a 164% increase year-over-year.
- Profit margin: 14.75%, indicating strong conversion of sales into net profit.
- Operating margin: 14.89%, reflecting efficient operations and cost control.
- EBIT: €4.5 billion.
- Interest coverage ratio: -28.9x (reported) - reported as -28.9x in the data set.
- Price-to-Earnings (P/E) ratio: 28.70, implying the market values Safran at ~28.7 times trailing earnings.
| Metric | Value | Period / Notes |
|---|---|---|
| Return on Equity (ROE) | 36.93% | Dec 2025 (historical avg: 10.32%) |
| Net Income | €4.3 billion | Year ended 30 Jun 2025 (↑164% YoY) |
| Profit Margin | 14.75% | Trailing 12 months |
| Operating Margin | 14.89% | Trailing 12 months |
| EBIT | €4.5 billion | Trailing 12 months |
| Interest Coverage Ratio | -28.9x | Reported (negative value in dataset) |
| P/E Ratio | 28.70 | Market valuation multiple |
- High ROE and expanding margins point to strong profitability drivers: revenue recovery, operational leverage and cost discipline.
- Net income surge (+164% YoY) amplifies retained earnings and shareholder value potential.
- P/E of 28.70 suggests market is pricing growth and recovery expectations into the share price.
- Interest coverage reported as -28.9x in the available figures; investors should verify interest expense and non-operating items that may distort the ratio.
Safran SA (SAF.PA) - Debt vs. Equity Structure
Safran's capital structure shows a strong equity base supported by manageable debt levels and healthy cash flow coverage metrics. Key headline figures signal a conservative leverage stance relative to asset size and shareholder equity.- Total shareholder equity: €13.8 billion
- Total debt: €4.4 billion
- Total assets: €56.1 billion
- Total liabilities: €42.3 billion
| Metric | Value | Interpretation |
|---|---|---|
| Debt-to-Equity Ratio | 0.29 | Low financial leverage; equity-funded balance sheet |
| Debt / Free Cash Flow | 1.37 | Strong ability to repay debt from operating cash flow |
| Altman Z‑Score | 2.74 | 'Grey zone'-limited bankruptcy risk |
| Interest Coverage Ratio | -28.9x | Reported as -28.9x |
| Total Assets | €56.1 billion | Significant asset base |
| Total Liabilities | €42.3 billion | Liabilities smaller than assets by €13.8bn (equity) |
- Equity dominance: Equity (€13.8bn) represents the primary buffer against liabilities, supporting solvency and investor confidence.
- Modest leverage: Debt-to-equity of 0.29 indicates conservative borrowing relative to shareholders' funds.
- Cash flow coverage: Debt/FCF of 1.37 implies operating cash flows can service and reduce debt load relatively quickly.
- Credit distress indicator: Altman Z of 2.74 places Safran in a monitoring zone-neither clearly safe nor in immediate distress.
Safran SA (SAF.PA) - Liquidity and Solvency
Safran's balance sheet shows a mix of constrained near-term liquidity metrics alongside strong solvency and robust cash generation that support operational flexibility and investment capacity.- Current ratio: 0.93 - below 1.0, signaling potential difficulty meeting short-term obligations from current assets alone.
- Quick ratio: 0.66 - limited immediate liquidity when inventories and less-liquid items are excluded.
- Debt-to-equity ratio: 0.29 - low leverage, indicating a conservative capital structure and strong solvency.
- Cash and short-term investments: €7.0 billion - a significant liquid buffer to address near-term needs.
- Free cash flow (H1 2025): €1,834 million - strong mid-year cash generation.
- FY 2025 free cash flow guidance: €3.0-€3.2 billion - indicates continued robust cash conversion for the year.
| Metric | Value |
|---|---|
| Current ratio | 0.93 |
| Quick ratio | 0.66 |
| Debt-to-equity ratio | 0.29 |
| Cash & short-term investments | €7.0 billion |
| Free cash flow (H1 2025) | €1,834 million |
| FY 2025 FCF guidance | €3.0-€3.2 billion |
Safran SA (SAF.PA) - Valuation Analysis
Safran's current market metrics reveal a mix of high market confidence, lofty asset-based multiples, and divergent valuation signals when growth is accounted for.- Market capitalization: €122.6 billion - signaling strong investor demand and scale.
- Price-to-Book (P/B): 9.38 - the stock trades at a substantial premium to book value.
- EV/EBITDA: 46.44 - a very high multiple, reflecting elevated growth expectations or limited near-term EBITDA relative to enterprise value.
- PEG ratio: 0.04 - extremely low, which can indicate undervaluation once growth is priced in (or reflect denominator distortion from very high projected growth rates).
- Analyst mean price target: €337.82 - implying ~9.72% upside from the current price.
- Intrinsic value estimates: $8.08 to $246.78 per share - a wide range depending on methodology and assumptions.
| Metric | Value | Unit / Note |
|---|---|---|
| Market Capitalization | 122.6 | € billion |
| Price-to-Book (P/B) | 9.38 | times |
| EV/EBITDA | 46.44 | times |
| PEG Ratio | 0.04 | ratio |
| Analyst Mean Price Target | 337.82 | € per share |
| Implied Upside | ~9.72% | from current price |
| Intrinsic Value Range | 8.08 - 246.78 | $ per share (methodology-dependent) |
- Interpretation cues: a high P/B and EV/EBITDA point to premium expectations; the tiny PEG suggests that when projected growth is folded into valuation the stock may appear cheap, but the extreme disparity in intrinsic value estimates signals high model sensitivity to assumptions.
- Investor considerations: reconcile market multiples with underlying cash flow forecasts, margin trajectories, and aerospace-cycle drivers; review the linked corporate background for strategic context: Safran SA: History, Ownership, Mission, How It Works & Makes Money.
Safran SA (SAF.PA) Risk Factors
- Supply chain and production capability: disruptions in component supply (titanium, composites, electronic components), supplier insolvency, or factory outages can reduce aircraft engine deliveries and MRO throughput, directly hitting revenue recognition and aftermarket margins.
| Metric / Risk | Recent figure / exposure | Potential near-term impact |
|---|---|---|
| Group revenue (FY 2023) | €23.2bn | Top-line sensitivity to production slowdowns and MRO demand shifts |
| Net income (FY 2023) | €2.1bn | Profitability falls with margin compression from higher input costs |
| Net debt (end-2023) | €6.5bn | Leverage increases refinancing/interest sensitivity |
| R&D / CapEx (annual run-rate) | ~€1.2bn R&D; €2.0-2.5bn CapEx | High investment needs increase funding requirements if cash flow weakens |
| USD revenue exposure | ~55% (approx.) | EUR/USD moves materially affect reported revenue and margin |
- Tariffs & trade policy: tariffs on aerospace components, export controls or changes in U.S.-EU trade terms can raise procurement costs and constrain international sales channels.
- Currency fluctuations: a stronger euro vs. dollar reduces euro-reported revenue and operating profit when a majority of sales and contracts are USD-denominated; a 5% EUR appreciation can erode reported revenue by several hundred million euros.
- Interest rate changes: higher global rates raise borrowing costs on variable-rate debt and increase discount rates applied to long-term contracts and pension liabilities.
- Geopolitical tensions / defense demand: military spending shifts (either cuts or re-prioritizations) change order visibility in defense systems; tensions can increase short-term demand but create long-term procurement uncertainty.
- Technological & competitive pressure: competitors' breakthroughs in engine fuel efficiency, electrification, or alternative propulsion may force accelerated R&D and margin compression.
- Operational amplifiers and mitigants typically pursued by management:
- Supply chain resilience: dual/single-source redesign, strategic inventory buffers, long-term supplier contracts.
- Hedging: systematic currency hedges on USD exposure and commodity hedges for key inputs.
- Balance-sheet management: maintain liquidity reserves, revolving facilities and target leverage bands to absorb shocks.
- Portfolio & pricing: mix shift toward higher-margin aftermarket services and defense contracts; indexation clauses to pass through inflation/commodity cost increases.
| Risk | Likelihood | Estimated P&L sensitivity (annual) |
|---|---|---|
| Major supplier disruption | Medium | €200-600m revenue loss depending on duration |
| EUR/USD appreciation 10% | Medium | €300-700m negative on reported revenue; margin hit varies by hedging |
| 1% rise in funding costs | High | €20-60m incremental interest expense (approx.) |
| Defense budget reallocation (10% cut in target markets) | Low-Medium | €100-400m order deferral risk over 2-3 years |
| Competitive technology adoption | Medium | Margin squeeze of 1-3 percentage points without counter R&D/price actions |
- Key monitoring indicators for investors:
- Order intake and book-to-bill ratios for civil engines and MRO.
- Gross margin trends and aftermarket services growth rate.
- Hedging disclosures and realized FX gains/losses each quarter.
- Working capital days, supplier lead-times and inventory build.
- Net debt / EBITDA trajectory and available liquidity lines.
Safran SA (SAF.PA) Growth Opportunities
Safran's positioning across civil aerospace, defense, space and services creates multiple vectors for revenue expansion and margin improvement. Key drivers include engine deliveries, aftermarket penetration, strategic acquisitions, geographic expansion and sustained R&D investment.- LEAP engine ramp-up: Continued increases in LEAP deliveries and installed base growth expand OEM revenues and, critically, the higher-margin aftermarket spool.
- Aftermarket services expansion: Mature installed fleets generate recurring MRO, spare parts and digital services revenue that improve predictability and lifetime value per asset.
- Targeted acquisitions: Integrating flight control and actuation activities (recent strategic moves with Collins Aerospace assets) strengthens systems capabilities and cross-selling across platforms.
- Defense & space diversification: Growing exposure to military propulsion, avionics and space systems reduces cyclicality tied to commercial cycles and opens new contract streams.
- Geographic growth: Penetration into fast-growing markets (notably Asia-China and India) offers volume upside for both OEM and aftermarket segments.
- R&D-led innovation: Sustained R&D spending protects technological advantage in engines, avionics, electrification and hybrid systems.
| Item | Representative 2023-2024 Metric |
|---|---|
| Total revenue (approx.) | €22.6 billion |
| Aftermarket / services revenue | ~€7.5 billion |
| R&D expenditure (annual) | ~€1.2 billion |
| LEAP engines cumulative deliveries | ~16,000 units |
| Recent actuation/flight control acquisition consideration | Transaction scale ~€1.8-2.0 billion (indicative) |
| Defense & space revenue contribution | ~€6.5-7.0 billion |
| Emerging markets annual growth (China/India) | 5-8% CAGR (near-term demand) |
- Aftermarket leverage: Every incremental 1,000 LEAP engines in service typically translates into a multiyear stream of MRO and spares with blended margins materially above OEM margins; this is a key margin-expansion mechanism.
- Acquisition synergies: Integrating Collins-derived flight control and actuation activities should enable cross-selling into existing aircraft platforms and defense programs, improving revenue per platform and reducing unit costs via combined supply chains.
- R&D focus areas: Investment emphasis on fuel efficiency (next‑gen turbofan tech), digital predictive maintenance, and electrification positions Safran to capture future OEM and retrofit demand.
- Geographic tactics: Local MRO footprint expansion and JV partnerships in Asia can accelerate part sales and service revenue while mitigating export/market access risks.

Safran SA (SAF.PA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.